Articles tagged with 'Salmon' | Hospital for Special Surgery

Newsroom Hospital for Special Surgery (Salmon)

2023
November
13,
2023
| 17:05 PM America/New_York
Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the American College of Rheumatology (ACR) Convergence
Read more
July
04,
2023
| 13:05 PM America/New_York
Rheum Now featuring Mary K. Crow, MD, Jane E. Salmon, MD, Lisa R. Sammaritano, MD, Medha Barbhaiya, MD, MPH.
Read more
March
27,
2023
| 16:54 PM America/New_York
Very Well Family featuring Jane E. Salmon, MD and Caroline Siegel, MD
Read more
January
26,
2023
| 15:28 PM America/New_York
HSS Research Institute’s Jane E. Salmon, MD, is conducting a groundbreaking, interventional trial funded by the NIH and Lupus Foundation of America (LFA) to help patients with lupus and antiphospholipid syndrome (APS) (often seen in lupus patients)
Read more
2022
November
04,
2022
| 15:19 PM America/New_York
Healio Rheumatology featuring Jane E. Salmon, MD
Read more
June
02,
2022
| 10:00 AM America/New_York
A study that includes researchers at Hospital for Special Surgery (HSS) underscores the importance of a multidisciplinary medical team to counsel and provide care for women with systemic lupus erythematosus, the most common form of lupus, who become
Read more
April
21,
2022
| 12:04 PM America/New_York
The Lupus Foundation of America featuring Jane E. Salmon, MD
Read more
March
24,
2022
| 18:05 PM America/New_York
Lupus Research Alliance featuring Jane E. Salmon, MD
Read more
2021
March
31,
2021
| 15:14 PM America/New_York
Lupus Foundation of America featuring Jane E. Salmon, MD
Read more
January
29,
2021
| 22:06 PM America/New_York
Rheumatology Advisor “Rheum On Air" podcast featuring Jane E. Salmon, MD
Read more
2020
November
18,
2020
| 22:00 PM America/New_York
The Rheumatologist featuring Jane E. Salmon, MD
Read more
September
18,
2020
| 08:00 AM America/New_York
Thanks to the generous support of donors, Hospital for Special Surgery (HSS) has announced the funding of nine grants for projects related to the study of COVID-19. These projects reflect the institution’s expertise in basic, translational and
Read more
August
05,
2020
| 21:22 PM America/New_York
The Lupus Research Alliance featuring Jane E. Salmon, MD
Read more
March
27,
2020
| 12:53 PM America/New_York
Rheumatology Advisor featuring Jane E. Salmon, MD
Read more
2019
December
23,
2019
| 09:54 AM America/New_York
Medscape featuring Jane E. Salmon, MD
Read more
December
19,
2019
| 08:00 AM America/New_York
A successful phase III trial of anifrolumab in systemic lupus erythematosus (SLE), called TULIP-2 (Treatment of Uncontrolled Lupus via the Interferon Pathway–2), reported positive results in this week’s New England Journal of Medicine (NEJM).At
Read more
September
01,
2019
| 16:07 PM America/New_York
Weill Cornell Medicine featuring Jane E. Salmon, MD
Read more
April
08,
2019
| 10:55 AM America/New_York
Women who have healthy pregnancies tend to show distinct changes in the activities of immune genes starting early in pregnancy, while women who have complicated pregnancies tend to show clear departures from that pattern, according to a new study
Read more
January
15,
2019
| 07:00 AM America/New_York
Can krill oil improve the quality of life of people living with systemic lupus erythematous? A clinical trial, involving 20 centers in the United States, is currently enrolling patients to answer this question. Hospital for Special Surgery (HSS), in
Read more
2018
November
18,
2018
| 07:00 AM America/New_York
The Rheumatologist reports on a new study that found that the incidence of lupus nephritis in patients with systemic lupus erythematosus (SLE) has decreased over the past 50 years. This retrospective study included 499 patients diagnosed with lupus
Read more
October
18,
2018
| 07:00 AM America/New_York
In an article by The Rheumatologist, Jane E. Salmon, MD, rheumatologist at HSS, addressed historical case studies by dermatologist Moriz Kaposi, MD, on systemic lupus erythematosus. "Earlier physicians had done wonderful work and wrote eloquent
Read more
Tags
August
29,
2018
| 07:00 AM America/New_York
Lupus News Today reported that HSS rheumatologist Jane E. Salmon, MD, is launching a clinical trial to assess the benefits of fatty-rich krill oil in lupus patients. "This trial reflects our responsiveness to patient wishes — a treatment that is
Read more
Tags
July
06,
2018
| 07:00 AM America/New_York
Mary K. Crow, MD, physician-in-chief and chief of Rheumatology, and Jane E. Salmon, MD, rheumatologist at Hospital for Special Surgery (HSS), have been named honorary members of the European League Against Rheumatism (EULAR) during the Annual
Read more
April
03,
2018
| 07:00 AM America/New_York
Rheumatology Advisor reporter Tori Rodriguez writes on using statins for cardiovascular risk reduction in rheumatoid arthritis patients. She interviews Jane E. Salmon, MD, rheumatologist at HSS, who explains that statins have pleiotropic effects,
Read more
April
03,
2018
| 07:00 AM America/New_York
Healio Rheumatology reports on a recent HSS study, published in the Journal of Clinical Investigation, which found that inhibiting the inactive rhomboid 2 protein could help physicians prevent kidney injury in patients with systemic
Read more
April
02,
2018
| 07:00 AM America/New_York
HSS researchers found that suppressing the inflammatory protein iRhom2 reduced inflammation and prevented kidney damage in those with lupus, Lupus News Today reported. Findings indicated that the protein ADAM17 plays a key role in inflammatory
Read more
March
20,
2018
| 08:00 AM America/New_York
A protein that helps regulate the body’s inflammatory system appears to play a critical role in causing kidney damage in patients with lupus and could be a target for future treatments for autoimmune disease, a new study has found. Researchers at
Read more
February
20,
2018
| 07:00 AM America/New_York
In pregnant patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (aPL), increased levels of complement activation products, specifically Bb and sC5b-9, early in pregnancy is strongly predictive of adverse pregnancy
Read more
February
07,
2018
| 07:00 AM America/New_York
Healio Rheumatology featured a recent study by HSS rheumatologist Jane E. Salmon, MD, that found that increased plasma levels of complements Bb and sC5b-9 are predictive of adverse outcomes among pregnant women with lupus. According to the
Read more
January
19,
2018
| 07:00 AM America/New_York
Rheumatic diseases affect women two to four times more often than men. Studying the sex differences in autoimmune conditions has been the focus of the Barbara Volcker Center for Women and Rheumatic Diseases at Hospital for Special Surgery. In a
Read more